BASIC RESEARCH GROUP CORE 005 ? CELL IMAGING SHARED RESOURCE PROJECT SUMMARY/ABSTRACT The overall goal of the Cell Imaging Shared Resource (CISR) is to supply Vanderbilt-Ingram Cancer Center (VICC) investigators with access to cutting-edge technology and expert technical support for microscopic observation and analysis of tissue and cellular anatomy and physiology essential to modern cancer research. The CISR maintains the full range of advanced microscopy and digital imaging capabilities fundamental to current cancer research methodology. CISR services have supported significant numbers of studies, in more than 100 cancer research laboratories, relevant to the mission of the VICC. Results from CISR services have been included in more than 120 VICC investigator publications during the past three years. Steady progress in microscopy-related research support of VICC investigators continues to facilitate high-quality data and more competitive research outcomes. The VICC provides administrative assistance for this shared resource, including human resource functions, purchasing and general advice regarding day-to-day operations. The VICC leadership works closely with the CISR on customer surveys that allow efficient strategic planning and operational oversight. The CISR recently added two new ?super resolution? microscopes (API OMX SIM ?Structured Illumination Microscopy,? and Nikon STORM ?Stochastic Optical Reconstruction Microscopy?), which will keep the shared resource at the forefront of new technology. The CISR, founded as a Cancer Center Microscopy Core in 1993, is a successful model for efficient utilization of expensive resources and dedicated expertise. VICC investigators continue to obtain both significant cost advantages and vital access to a large array of valuable, advanced instrumentation and dedicated expertise from the CISR, thus enabling and accelerating cancer research that would otherwise be reduced in quantity and quality.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-19
Application #
8934378
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-09-17
Project End
2020-08-31
Budget Start
2015-09-07
Budget End
2016-08-31
Support Year
19
Fiscal Year
2015
Total Cost
$129,097
Indirect Cost
$46,870
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Maacha, Selma; Hong, Jun; von Lersner, Ariana et al. (2018) AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking. Neoplasia 20:1008-1022
Schulte, Michael L; Fu, Allie; Zhao, Ping et al. (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194-202
Petersen, Christine P; Meyer, Anne R; De Salvo, Carlo et al. (2018) A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach. Gut 67:805-817
Wang, Jing; Zhao, Yue; Zhou, Xiaofan et al. (2018) Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation. BMC Genomics 19:633
Galligan, James J; Wepy, James A; Streeter, Matthew D et al. (2018) Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. Proc Natl Acad Sci U S A 115:9228-9233
Davenport, James R; Su, Timothy; Zhao, Zhiguo et al. (2018) Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut 67:456-465
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719

Showing the most recent 10 out of 2462 publications